Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists

A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2004-04, Vol.14 (7), p.1651-1654
Hauptverfasser: Huryn, Donna M, Ashwell, Susan, Baudy, Reinhardt, Dressen, Darren B, Gallaway, William, Grant, Francine S, Konradi, Andrei, Ley, Robert W, Petusky, Susan, Pleiss, Michael A, Sarantakis, Dimitri, Semko, Christopher M, Sherman, Mary M, Tio, Cesar, Zhang, Lu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1654
container_issue 7
container_start_page 1651
container_title Bioorganic & medicinal chemistry letters
container_volume 14
creator Huryn, Donna M
Ashwell, Susan
Baudy, Reinhardt
Dressen, Darren B
Gallaway, William
Grant, Francine S
Konradi, Andrei
Ley, Robert W
Petusky, Susan
Pleiss, Michael A
Sarantakis, Dimitri
Semko, Christopher M
Sherman, Mary M
Tio, Cesar
Zhang, Lu
description A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising compounds were identified for in vivo pharmacokinetic evaluation. These studies resulted in the identification of a pro-drug that exhibited desirable blood levels in PK studies in several different species. A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described.
doi_str_mv 10.1016/j.bmcl.2004.01.062
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71733144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X04001428</els_id><sourcerecordid>71733144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-f531d73b5da1635f33f3ef88a997b5976c8d9ea4edc0f47c879a00947bbdb4263</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoOo7-ARcyG13ZetPcvsCNiC8YcOEDdyFNbsYMnVaTVtBfb8sM6MrV5cJ3DoePsSMOMQeenS_jaqXrOAHAGHgMWbLFJhwzjARCus0mUGYQFSW-7rH9EJYAHAFxl-3xFJIMUEzY_PGr6d4ouHA202_KK92Rd9-qc20zU42Z0aeq-_Xb2tm7byPj-0UYn5f5ZYQD1KlF27jQhQO2Y1Ud6HBzp-z55vrp6i6aP9zeX13OIy0K7CKbCm5yUaVG8UykVggryBaFKsu8Sss804UpSSEZDRZzXeSlAigxrypTYZKJKTtd9w5zPnoKnVy5oKmuVUNtH2TOcyE44gAma1D7NgRPVr57t1L-S3KQo0O5lKNDOTqUwOXgcAgdb9r7akXmN7KRNgAnG0AFrWrrVaNd-MOl6TB5nHmx5mhw8enIy6AdNZqM86Q7aVr3344fp66Pdg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71733144</pqid></control><display><type>article</type><title>Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Huryn, Donna M ; Ashwell, Susan ; Baudy, Reinhardt ; Dressen, Darren B ; Gallaway, William ; Grant, Francine S ; Konradi, Andrei ; Ley, Robert W ; Petusky, Susan ; Pleiss, Michael A ; Sarantakis, Dimitri ; Semko, Christopher M ; Sherman, Mary M ; Tio, Cesar ; Zhang, Lu</creator><creatorcontrib>Huryn, Donna M ; Ashwell, Susan ; Baudy, Reinhardt ; Dressen, Darren B ; Gallaway, William ; Grant, Francine S ; Konradi, Andrei ; Ley, Robert W ; Petusky, Susan ; Pleiss, Michael A ; Sarantakis, Dimitri ; Semko, Christopher M ; Sherman, Mary M ; Tio, Cesar ; Zhang, Lu</creatorcontrib><description>A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising compounds were identified for in vivo pharmacokinetic evaluation. These studies resulted in the identification of a pro-drug that exhibited desirable blood levels in PK studies in several different species. A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2004.01.062</identifier><identifier>PMID: 15026043</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Cell Adhesion ; Drug Evaluation, Preclinical - methods ; Integrin alpha4beta1 - antagonists &amp; inhibitors ; Integrin alpha4beta1 - metabolism ; Male ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; Physico-chemical characterization ; Pro-drugs ; Prodrugs - chemical synthesis ; Prodrugs - metabolism ; Rats ; VLA-4 antagonist</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2004-04, Vol.14 (7), p.1651-1654</ispartof><rights>2004 Elsevier Ltd</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-f531d73b5da1635f33f3ef88a997b5976c8d9ea4edc0f47c879a00947bbdb4263</citedby><cites>FETCH-LOGICAL-c384t-f531d73b5da1635f33f3ef88a997b5976c8d9ea4edc0f47c879a00947bbdb4263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2004.01.062$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15558796$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15026043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huryn, Donna M</creatorcontrib><creatorcontrib>Ashwell, Susan</creatorcontrib><creatorcontrib>Baudy, Reinhardt</creatorcontrib><creatorcontrib>Dressen, Darren B</creatorcontrib><creatorcontrib>Gallaway, William</creatorcontrib><creatorcontrib>Grant, Francine S</creatorcontrib><creatorcontrib>Konradi, Andrei</creatorcontrib><creatorcontrib>Ley, Robert W</creatorcontrib><creatorcontrib>Petusky, Susan</creatorcontrib><creatorcontrib>Pleiss, Michael A</creatorcontrib><creatorcontrib>Sarantakis, Dimitri</creatorcontrib><creatorcontrib>Semko, Christopher M</creatorcontrib><creatorcontrib>Sherman, Mary M</creatorcontrib><creatorcontrib>Tio, Cesar</creatorcontrib><creatorcontrib>Zhang, Lu</creatorcontrib><title>Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising compounds were identified for in vivo pharmacokinetic evaluation. These studies resulted in the identification of a pro-drug that exhibited desirable blood levels in PK studies in several different species. A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell Adhesion</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Integrin alpha4beta1 - antagonists &amp; inhibitors</subject><subject>Integrin alpha4beta1 - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>Physico-chemical characterization</subject><subject>Pro-drugs</subject><subject>Prodrugs - chemical synthesis</subject><subject>Prodrugs - metabolism</subject><subject>Rats</subject><subject>VLA-4 antagonist</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMoOo7-ARcyG13ZetPcvsCNiC8YcOEDdyFNbsYMnVaTVtBfb8sM6MrV5cJ3DoePsSMOMQeenS_jaqXrOAHAGHgMWbLFJhwzjARCus0mUGYQFSW-7rH9EJYAHAFxl-3xFJIMUEzY_PGr6d4ouHA202_KK92Rd9-qc20zU42Z0aeq-_Xb2tm7byPj-0UYn5f5ZYQD1KlF27jQhQO2Y1Ud6HBzp-z55vrp6i6aP9zeX13OIy0K7CKbCm5yUaVG8UykVggryBaFKsu8Sss804UpSSEZDRZzXeSlAigxrypTYZKJKTtd9w5zPnoKnVy5oKmuVUNtH2TOcyE44gAma1D7NgRPVr57t1L-S3KQo0O5lKNDOTqUwOXgcAgdb9r7akXmN7KRNgAnG0AFrWrrVaNd-MOl6TB5nHmx5mhw8enIy6AdNZqM86Q7aVr3344fp66Pdg</recordid><startdate>20040405</startdate><enddate>20040405</enddate><creator>Huryn, Donna M</creator><creator>Ashwell, Susan</creator><creator>Baudy, Reinhardt</creator><creator>Dressen, Darren B</creator><creator>Gallaway, William</creator><creator>Grant, Francine S</creator><creator>Konradi, Andrei</creator><creator>Ley, Robert W</creator><creator>Petusky, Susan</creator><creator>Pleiss, Michael A</creator><creator>Sarantakis, Dimitri</creator><creator>Semko, Christopher M</creator><creator>Sherman, Mary M</creator><creator>Tio, Cesar</creator><creator>Zhang, Lu</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040405</creationdate><title>Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists</title><author>Huryn, Donna M ; Ashwell, Susan ; Baudy, Reinhardt ; Dressen, Darren B ; Gallaway, William ; Grant, Francine S ; Konradi, Andrei ; Ley, Robert W ; Petusky, Susan ; Pleiss, Michael A ; Sarantakis, Dimitri ; Semko, Christopher M ; Sherman, Mary M ; Tio, Cesar ; Zhang, Lu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-f531d73b5da1635f33f3ef88a997b5976c8d9ea4edc0f47c879a00947bbdb4263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell Adhesion</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Integrin alpha4beta1 - antagonists &amp; inhibitors</topic><topic>Integrin alpha4beta1 - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>Physico-chemical characterization</topic><topic>Pro-drugs</topic><topic>Prodrugs - chemical synthesis</topic><topic>Prodrugs - metabolism</topic><topic>Rats</topic><topic>VLA-4 antagonist</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huryn, Donna M</creatorcontrib><creatorcontrib>Ashwell, Susan</creatorcontrib><creatorcontrib>Baudy, Reinhardt</creatorcontrib><creatorcontrib>Dressen, Darren B</creatorcontrib><creatorcontrib>Gallaway, William</creatorcontrib><creatorcontrib>Grant, Francine S</creatorcontrib><creatorcontrib>Konradi, Andrei</creatorcontrib><creatorcontrib>Ley, Robert W</creatorcontrib><creatorcontrib>Petusky, Susan</creatorcontrib><creatorcontrib>Pleiss, Michael A</creatorcontrib><creatorcontrib>Sarantakis, Dimitri</creatorcontrib><creatorcontrib>Semko, Christopher M</creatorcontrib><creatorcontrib>Sherman, Mary M</creatorcontrib><creatorcontrib>Tio, Cesar</creatorcontrib><creatorcontrib>Zhang, Lu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huryn, Donna M</au><au>Ashwell, Susan</au><au>Baudy, Reinhardt</au><au>Dressen, Darren B</au><au>Gallaway, William</au><au>Grant, Francine S</au><au>Konradi, Andrei</au><au>Ley, Robert W</au><au>Petusky, Susan</au><au>Pleiss, Michael A</au><au>Sarantakis, Dimitri</au><au>Semko, Christopher M</au><au>Sherman, Mary M</au><au>Tio, Cesar</au><au>Zhang, Lu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2004-04-05</date><risdate>2004</risdate><volume>14</volume><issue>7</issue><spage>1651</spage><epage>1654</epage><pages>1651-1654</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising compounds were identified for in vivo pharmacokinetic evaluation. These studies resulted in the identification of a pro-drug that exhibited desirable blood levels in PK studies in several different species. A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15026043</pmid><doi>10.1016/j.bmcl.2004.01.062</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2004-04, Vol.14 (7), p.1651-1654
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_71733144
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Biological and medical sciences
Cell Adhesion
Drug Evaluation, Preclinical - methods
Integrin alpha4beta1 - antagonists & inhibitors
Integrin alpha4beta1 - metabolism
Male
Medical sciences
Miscellaneous
Pharmacology. Drug treatments
Physico-chemical characterization
Pro-drugs
Prodrugs - chemical synthesis
Prodrugs - metabolism
Rats
VLA-4 antagonist
title Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T21%3A25%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20characterization%20and%20evaluation%20of%20pro-drugs%20of%20VLA-4%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Huryn,%20Donna%20M&rft.date=2004-04-05&rft.volume=14&rft.issue=7&rft.spage=1651&rft.epage=1654&rft.pages=1651-1654&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2004.01.062&rft_dat=%3Cproquest_cross%3E71733144%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71733144&rft_id=info:pmid/15026043&rft_els_id=S0960894X04001428&rfr_iscdi=true